Biotech Firm With $10 Billion Valuation ‘Resurrects’ Dire Wolves

Colossal Biosciences Inc., a Dallas-based biotech firm with a $10 billion valuation, has announced a new breakthrough in its audacious mission to resurrect extinct animals.

The company said on Monday it’s created three dire wolves, a species popularized by the fantasy series Game of Thrones but not seen on Earth in more than 12,000 years.

Privately-held Colossal first gained fame in 2022 when it announced its goal to bring the woolly mammoth back to life — though it’s only so far managed to create a woolly mouse. The company has pitched its gene-editing technology as not just a way to bring back prehistoric wonders, ...